Nikko Asset Management Americas, Inc. Beam Therapeutics Inc. Transaction History

Nikko Asset Management Americas, Inc.

  • $8.64 Billion
  • Q3 2024

A detailed history of Nikko Asset Management Americas, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 3,552,829 shares of BEAM stock, worth $87 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
3,552,829
Previous 2,224,415 59.72%
Holding current value
$87 Million
Previous $52.1 Million 67.01%
% of portfolio
1.01%
Previous 0.61%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$22.57 - $33.14 $30 Million - $44 Million
1,328,414 Added 59.72%
3,552,829 $87 Million
Q2 2024

Aug 09, 2024
SELL
$21.22 - $32.66 $2.92 Million - $4.49 Million
-137,402 Reduced 5.82%
2,224,415 $52.1 Million
Q1 2024

May 02, 2024
BUY
$23.46 - $45.07 $87,411 - $167,930
3,726 Added 0.16%
2,361,817 $78 Million
Q4 2023

Feb 08, 2024
BUY
$17.69 - $30.76 $12.7 Million - $22 Million
715,911 Added 43.6%
2,358,091 $64.2 Million
Q3 2023

Nov 09, 2023
BUY
$23.01 - $32.46 $9.83 Million - $13.9 Million
427,100 Added 35.15%
1,642,180 $39.5 Million
Q2 2023

Aug 14, 2023
BUY
$29.32 - $35.99 $16.3 Million - $20 Million
556,514 Added 84.5%
1,215,080 $38.8 Million
Q1 2023

May 03, 2023
SELL
$30.15 - $48.79 $455,988 - $737,899
-15,124 Reduced 2.24%
658,566 $20.2 Million
Q4 2022

Feb 13, 2023
BUY
$36.73 - $51.6 $5.98 Million - $8.4 Million
162,759 Added 31.86%
673,690 $26.3 Million
Q3 2022

Nov 14, 2022
BUY
$39.79 - $70.31 $8.71 Million - $15.4 Million
218,969 Added 75.0%
510,931 $23.8 Million
Q2 2022

Aug 04, 2022
BUY
$29.86 - $62.36 $252,406 - $527,129
8,453 Added 2.98%
291,962 $10.8 Million
Q1 2022

May 06, 2022
BUY
$53.73 - $82.16 $3.13 Million - $4.79 Million
58,286 Added 25.88%
283,509 $16.3 Million
Q4 2021

Feb 08, 2022
SELL
$68.02 - $99.06 $1.98 Million - $2.89 Million
-29,132 Reduced 11.45%
225,223 $18 Million
Q3 2021

Nov 09, 2021
BUY
$84.37 - $133.6 $61,083 - $96,726
724 Added 0.29%
254,355 $22.1 Million
Q2 2021

Aug 09, 2021
BUY
$64.12 - $128.71 $1.55 Million - $3.12 Million
24,230 Added 10.56%
253,631 $33 Million
Q1 2021

May 03, 2021
BUY
$71.28 - $120.75 $1.79 Million - $3.04 Million
25,159 Added 12.32%
229,401 $18.4 Million
Q4 2020

Feb 11, 2021
BUY
$22.24 - $95.63 $4.54 Million - $19.5 Million
204,242 New
204,242 $16.7 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.72B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email